Contact
searchSearch
HMP Global

Eczema Topic Center

Featured

Jonathan Silverberg, MD, PhD, MPH
Podcasts
Insights on Baricitinib for Atopic Dermatitis
02/17/2022
Jonathan Silverberg, MD
Dr Jonathan Silverberg discusses baricitinib in relation to his recently published study.
Dr Jonathan Silverberg discusses baricitinib in relation to his recently published study.
Dr Jonathan Silverberg discusses...
02/17/2022
The Dermatologist
News
Dental Personnel Are At Risk of Developing Occupational Contact Dermatitis
01/31/2022
Jessica Garlewicz
Researchers aimed to determine the prevalence of occupational contact dermatitis in dental personnel referred for patch testing and characterize relevant allergens.
Researchers aimed to determine the prevalence of occupational contact dermatitis in dental personnel referred for patch testing and characterize relevant allergens.
Researchers aimed to determine...
01/31/2022
The Dermatologist
eczema legs severe
FDA Alerts
Upadacitinib Approved for Patients with Moderate to Severe AD
01/15/2022
Lauren Mateja
Upadacitinib, an oral JAK1 inhibitor, was approved for the treatment of moderate to severe AD in patients aged 12 years and older.
Upadacitinib, an oral JAK1 inhibitor, was approved for the treatment of moderate to severe AD in patients aged 12 years and older.
Upadacitinib, an oral JAK1...
01/15/2022
The Dermatologist
severe eczema lichenification
FDA Alerts
FDA Approves Abrocitinib for Moderate to Severe AD
01/14/2022
Lauren Mateja
Abrocitinib received FDA approval for the treatment of moderate to severe AD in adults whose disease was not adequately controlled with other systemic therapies.
Abrocitinib received FDA approval for the treatment of moderate to severe AD in adults whose disease was not adequately controlled with other systemic therapies.
Abrocitinib received FDA...
01/14/2022
The Dermatologist
severe eczema on the legs
FDA Alerts
Tralokinumab Receives FDA Approval for Atopic Dermatitis in Adults
12/28/2021
Lauren Mateja
Novel biologic tralokinumab, an anti-IL-13 biologic, received FDA approval for the treatment of moderate to severe atopic dermatitis in adults.
Novel biologic tralokinumab, an anti-IL-13 biologic, received FDA approval for the treatment of moderate to severe atopic dermatitis in adults.
Novel biologic tralokinumab, an...
12/28/2021
The Dermatologist
Dr Jonathan Silverberg
Conference Preview
Sneak Peek: Revolutionizing Atopic Dermatitis 2021
11/12/2021
In the third annual meeting, Revolutionizing Atopic Dermatitis Conference 2021 features 25 experts in the diagnosis, treatment, and management of atopic dermatitis.
In the third annual meeting, Revolutionizing Atopic Dermatitis Conference 2021 features 25 experts in the diagnosis, treatment, and management of atopic dermatitis.
In the third annual meeting,...
11/12/2021
The Dermatologist
News
Atopic Dermatitis Poses Significant Financial Burden on Patients
11/03/2021
Lauren Mateja
Researchers found that atopic dermatitis poses a significant burden on direct and indirect health care costs for adults with the disease.
Researchers found that atopic dermatitis poses a significant burden on direct and indirect health care costs for adults with the disease.
Researchers found that atopic...
11/03/2021
The Dermatologist
News
Study Results Hint at Relationship Between Addiction and Atopic Dermatitis
11/03/2021
Lauren Mateja
There may be elevated positive screening rates for addictive behaviors in people with atopic dermatitis (AD) vs the general population.
There may be elevated positive screening rates for addictive behaviors in people with atopic dermatitis (AD) vs the general population.
There may be elevated positive...
11/03/2021
The Dermatologist
Eczema, or atopic dermatitis shown here, can have severe impacts on children and adolescent mental health.
Quiz
Trivia: Atopic Dermatitis and Mental Health
10/07/2021
Which of these options accurately name the mental health disorder associated with AD in children and adolescents?
Which of these options accurately name the mental health disorder associated with AD in children and adolescents?
Which of these options...
10/07/2021
The Dermatologist
News
Atopic Dermatitis Associated with Cardiovascular Disease
09/24/2021
Lisa Kuhns, PhD, MD
Patients with atopic dermatitis (AD) and metabolic disorders are at risk for developing cardiovascular disease (CVD) and major cardiovascular events (MACE), according to a study published in Dermatology and Therapy. Researchers aimed to...
Patients with atopic dermatitis (AD) and metabolic disorders are at risk for developing cardiovascular disease (CVD) and major cardiovascular events (MACE), according to a study published in Dermatology and Therapy. Researchers aimed to...
Patients with atopic dermatitis...
09/24/2021
The Dermatologist
Eczema Cream
Crisaborole Efficacious and Well Tolerated in Patients With Mild to Moderate AD
09/24/2021
Lisa Kuhns, PhD, MD
Crisaborole is well tolerated and effective in patients with mild to moderate atopic dermatitis (AD) and other comorbidities, according to a recent study published in Allergy and Asthma Proceedings. Researchers performed a post hoc...
Crisaborole is well tolerated and effective in patients with mild to moderate atopic dermatitis (AD) and other comorbidities, according to a recent study published in Allergy and Asthma Proceedings. Researchers performed a post hoc...
Crisaborole is well tolerated...
09/24/2021
The Dermatologist

Quizzes

Eczema, or atopic dermatitis shown here, can have severe impacts on children and adolescent mental health.
Quiz
Trivia: Atopic Dermatitis and Mental Health
10/07/2021
Which of these options accurately name the mental health disorder associated with AD in children and adolescents?
Which of these options accurately name the mental health disorder associated with AD in children and adolescents?
Which of these options...
10/07/2021
The Dermatologist
A Black doctor performs a skin examination on a skin of color patient for diseases such as eczema
Quiz
Trivia: Black Children With Atopic Disease
08/24/2021
Which of these options accurately lists age range at which children develop atopy when mothers produced a smaller inflammatory response during pregnancy?
Which of these options accurately lists age range at which children develop atopy when mothers produced a smaller inflammatory response during pregnancy?
Which of these options...
08/24/2021
The Dermatologist
eczema
Quiz
Trivia: AD Phenotypes: Itch and Lesional Severity
06/18/2021
Which of the choices correctly highlights the links between patients with severe itch and milder lesions, and patients with mild itch and severe lesions?
Which of the choices correctly highlights the links between patients with severe itch and milder lesions, and patients with mild itch and severe lesions?
Which of the choices correctly...
06/18/2021
The Dermatologist
Quiz
Type 2 Inflammation and Early Systemic Therapy in Pediatric Atopic Dermatitis
04/05/2026
Riya Gandhi, MA
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical...
04/05/2026
The Dermatologist
Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist
Quiz
Type 2 Inflammation as a Pathogenic Driver in Prurigo Nodularis
03/05/2026
Riya Gandhi, MA
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how...
03/05/2026
The Dermatologist
psoriasis
Quiz
Distinguishing Feature of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing...
03/02/2026
The Dermatologist
psoriasis
Quiz
Quiz: Misdiagnosis of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized...
03/02/2026
The Dermatologist
Quiz
Allergic Disease Progression: Genetics and Environment
02/26/2026
Riya Gandhi, MA
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between...
02/26/2026
The Dermatologist
Quiz
Early Intervention Strategies in Pediatric Atopic Dermatitis
02/26/2026
Riya Gandhi, MA
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of...
02/26/2026
The Dermatologist
Quiz
Air Pollution and Atopic Disease: Evaluating Epidemiologic Evidence
02/26/2026
Riya Gandhi, MA
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the...
02/26/2026
The Dermatologist

Multimedia

Jonathan Silverberg, MD, PhD, MPH
Podcasts
Insights on Baricitinib for Atopic Dermatitis
02/17/2022
Jonathan Silverberg, MD
Dr Jonathan Silverberg discusses baricitinib in relation to his recently published study.
Dr Jonathan Silverberg discusses baricitinib in relation to his recently published study.
Dr Jonathan Silverberg discusses...
02/17/2022
The Dermatologist
Jeff Yu, MD, one of the speakers at Summer Meeting AAD regarding pediatric contact dermatitis treatment.
Videos
Contact Dermatitis: Pediatric and Session Insights
09/01/2021
In this video, Dr Jeff Yu gives insights into pediatric contact dermatitis and talks about his session from AAD Summer Meeting.
In this video, Dr Jeff Yu gives insights into pediatric contact dermatitis and talks about his session from AAD Summer Meeting.
In this video, Dr Jeff Yu gives...
09/01/2021
The Dermatologist
Jeff Yu, MD, one of the speakers at Summer Meeting AAD regarding contact dermatitis treatment and approaches.
Videos
Contact Dermatitis: Treatments and Patient Approaches
09/01/2021
In this video, Dr Jeff Yu shares how to implement new treatments and approaches for patients with contact dermatitis.  
In this video, Dr Jeff Yu shares how to implement new treatments and approaches for patients with contact dermatitis.  
In this video, Dr Jeff Yu shares...
09/01/2021
The Dermatologist
silverberg
Podcasts
Nailing the Patch Test: The Basics
12/04/2020
In the Nailing the Patch Test podcast series, Jonathan Silverberg, MD, will discuss various aspects of patch testing, diagnosing allergens, and more. In this episode, he reviews the some of the basics of patch testing.
In the Nailing the Patch Test podcast series, Jonathan Silverberg, MD, will discuss various aspects of patch testing, diagnosing allergens, and more. In this episode, he reviews the some of the basics of patch testing.
In the Nailing the Patch Test...
12/04/2020
The Dermatologist
Heberton
Videos
Managing EGFR Skin Toxicities
04/01/2026
Riya Gandhi, MA
This interview focuses on the most common EGFR inhibitor–associated skin adverse events, when they typically emerge, and practical strategies to reduce severity—including skincare routines, photoprotection, and prophylactic approaches.
This interview focuses on the most common EGFR inhibitor–associated skin adverse events, when they typically emerge, and practical strategies to reduce severity—including skincare routines, photoprotection, and prophylactic approaches.
This interview focuses on the...
04/01/2026
The Dermatologist
Amy paller
Videos
Disease Biology and Early Recognition in Atopic Dermatitis
04/01/2026
Amy S. Paller, MD, MS; Riya Gandhi, MA
Dr Amy Paller discusses how recognizing pediatric atopic dermatitis as a type 2 inflammatory disease has transformed early treatment strategies, enabling safer and more proactive use of targeted therapies.
Dr Amy Paller discusses how recognizing pediatric atopic dermatitis as a type 2 inflammatory disease has transformed early treatment strategies, enabling safer and more proactive use of targeted therapies.
Dr Amy Paller discusses how...
04/01/2026
The Dermatologist
Joseph F. Merola, MD, MMSc, and Colby Evans, MD
Videos
Autoimmune Serologies in Dermatology
04/01/2026
Riya Gandhi, MA
Dr Joseph Merola breaks down how dermatologists can accurately interpret autoimmune serologies, with a focus on ANA testing, clinical context, and avoiding unnecessary labs.
Dr Joseph Merola breaks down how dermatologists can accurately interpret autoimmune serologies, with a focus on ANA testing, clinical context, and avoiding unnecessary labs.
Dr Joseph Merola breaks down how...
04/01/2026
The Dermatologist
Melissa Mauskar, MD
Videos
Practical Pearls of Vulvar Dermatoses
04/01/2026
Riya Gandhi, MA
Dr Melissa Mauskar discusses common diagnostic pitfalls in vulvar dermatoses, including overlapping conditions and misdiagnosis of lichen sclerosus versus genitourinary syndrome of menopause.
Dr Melissa Mauskar discusses common diagnostic pitfalls in vulvar dermatoses, including overlapping conditions and misdiagnosis of lichen sclerosus versus genitourinary syndrome of menopause.
Dr Melissa Mauskar discusses...
04/01/2026
The Dermatologist
Guttman
Videos
Chronic Hand Eczema: Pathways and Emerging Therapies
04/01/2026
Riya Gandhi, MA
Dr Emma Guttman explains how chronic hand eczema is now understood as a heterogeneous disease driven by different immune pathways depending on underlying causes.
Dr Emma Guttman explains how chronic hand eczema is now understood as a heterogeneous disease driven by different immune pathways depending on underlying causes.
Dr Emma Guttman explains how...
04/01/2026
The Dermatologist
Elman
Videos
Baseline Screening and Monitoring for Biologics and Small Molecules
04/01/2026
Scott Andrew Elman, MD, FAAD; Riya Gandhi, MA
Are dermatologists overtesting patients on biologics and new oral therapies? Dr Scott Elman explains how mechanism-based screening can reduce unnecessary testing while maintaining patient safety.
Are dermatologists overtesting patients on biologics and new oral therapies? Dr Scott Elman explains how mechanism-based screening can reduce unnecessary testing while maintaining patient safety.
Are dermatologists overtesting...
04/01/2026
The Dermatologist
brad glick
Videos
Oral Therapies in Psoriasis
04/01/2026
Riya Gandhi, MA
Dr Brad Glick discusses persistent unmet needs in psoriasis care, including undertreatment, low systemic therapy adoption, and challenges in high-impact disease areas.
Dr Brad Glick discusses persistent unmet needs in psoriasis care, including undertreatment, low systemic therapy adoption, and challenges in high-impact disease areas.
Dr Brad Glick discusses...
04/01/2026
The Dermatologist
Videos
Hidradenitis Suppurativa: Early Recognition, IL-17 Targeted Therapies, and Multidisciplinary Care
04/01/2026
Riya Gandhi, MA
Dr Jack O’Brien discusses how dermatologists can reduce diagnostic delays in hidradenitis suppurativa by recognizing early clinical signs such as recurrent abscesses in intertriginous areas and associated acne.
Dr Jack O’Brien discusses how dermatologists can reduce diagnostic delays in hidradenitis suppurativa by recognizing early clinical signs such as recurrent abscesses in intertriginous areas and associated acne.
Dr Jack O’Brien discusses how...
04/01/2026
The Dermatologist
Asempa
Videos
Improving Dermatology Measures for Skin of Color and Underrepresented Groups
04/01/2026
Riya Gandhi, MA
This interview examines the limitations of commonly used dermatology outcome measures in patients with skin of color and other underrepresented populations.
This interview examines the limitations of commonly used dermatology outcome measures in patients with skin of color and other underrepresented populations.
This interview examines the...
04/01/2026
The Dermatologist
Orgill
Videos
Mohs Reconstruction Collaboration
04/01/2026
Riya Gandhi, MA
Dr Dennis Orgill discusses when dermatologists should involve plastic surgeons after Mohs surgery, particularly for complex defects in high-visibility areas such as the nose, eyes, and mouth.
Dr Dennis Orgill discusses when dermatologists should involve plastic surgeons after Mohs surgery, particularly for complex defects in high-visibility areas such as the nose, eyes, and mouth.
Dr Dennis Orgill discusses when...
04/01/2026
The Dermatologist

From the Issue

Partner Approved
Empower Your Patients to Monitor Their Eczema Symptoms
12/14/2020
Lauren Mateja
Atopic dermatitis is a chronic disease requiring long-term monitoring of symptoms and triggers. Patients can proactively monitor their eczema with a new, easy-to-use mobile app.
Atopic dermatitis is a chronic disease requiring long-term monitoring of symptoms and triggers. Patients can proactively monitor their eczema with a new, easy-to-use mobile app.
Atopic dermatitis is a chronic...
12/14/2020
The Dermatologist
Partner Approved
Recent Research to Consider in the Treatment of Atopic Dermatitis and Eczema
07/15/2020
While much of research is to test the clinical efficacy and safety of drugs, these posters from the American Academy of Dermatology Virtual Meeting Experience 2020 focused on physician decision-making and evaluation, patient characteristics,...
While much of research is to test the clinical efficacy and safety of drugs, these posters from the American Academy of Dermatology Virtual Meeting Experience 2020 focused on physician decision-making and evaluation, patient characteristics,...
While much of research is to...
07/15/2020
The Dermatologist
NEA Approved Features
Supporting the Transition to Self-Managed Care in Adolescents and Young Adults With Atopic Dermatitis
03/09/2026
Allison Loiselle, PhD; Jessica Garlewicz
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association...
03/09/2026
The Dermatologist
NEA Approved Features
Patient Self-Monitoring and Shared Decision-Making in Atopic Dermatitis
12/09/2025
Jessica Garlewicz
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to...
12/09/2025
The Dermatologist
NEA Approved Features
Eczema Action Plans: Personalized Tools for Empowering Patients and Enhancing Care
09/08/2025
Jessica Garlewicz
National Eczema Association researchers offer practical guidance grounded in real-world patient and provider needs to optimize long-term atopic dermatitis control and better support patient self-management.
National Eczema Association researchers offer practical guidance grounded in real-world patient and provider needs to optimize long-term atopic dermatitis control and better support patient self-management.
National Eczema Association...
09/08/2025
The Dermatologist
NEA Approved Features
Eczema in the United States: Insights from a National Study on Prevalence and Co-Occurrence
06/05/2025
Lisa Kuhs, PhD
The All of Us database highlights the complexity of eczema beyond atopic dermatitis and emphasizes the need for a more nuanced approach in both clinical practice and research.
The All of Us database highlights the complexity of eczema beyond atopic dermatitis and emphasizes the need for a more nuanced approach in both clinical practice and research.
The All of Us database...
06/05/2025
The Dermatologist
NEA Approved Features
Addressing Acute Care Needs in Atopic Dermatitis: A Call for Improved Access and Management
03/06/2025
Lisa Kuhs, PhD
National Eczema Association survey examines the frequency of acute care needs among patients with atopic dermatitis and the wait times they experience when seeking care from their primary atopic dermatitis health care providers.
National Eczema Association survey examines the frequency of acute care needs among patients with atopic dermatitis and the wait times they experience when seeking care from their primary atopic dermatitis health care providers.
National Eczema Association...
03/06/2025
The Dermatologist
NEA Approved Features
What Constitutes a Flare? The Patient Perspective
12/02/2024
Jessica Garlewicz
Aligning patient and health care provider definitions can improve communication, treatment effectiveness, and research strategies.
Aligning patient and health care provider definitions can improve communication, treatment effectiveness, and research strategies.
Aligning patient and health care...
12/02/2024
The Dermatologist
NEA Approved Features
Mental Health Support for Patients With Atopic Dermatitis
09/06/2024
Jessica Garlewicz; Coleen Stern, MA
We know that the mental health burden of having atopic dermatitis is real, but are patients getting the help they need?
We know that the mental health burden of having atopic dermatitis is real, but are patients getting the help they need?
We know that the mental health...
09/06/2024
The Dermatologist
NEA Approved Features
The Impact of Atopic Dermatitis Symptoms on Mental Health
05/03/2024
Jessica Garlewicz
When patients are aware of the connection between their mental health and their eczema symptoms, they may be more likely to seek support.
When patients are aware of the connection between their mental health and their eczema symptoms, they may be more likely to seek support.
When patients are aware of the...
05/03/2024
The Dermatologist
NEA Approved Features
Atopic Dermatitis: Comorbidities and Treatment Challenges
12/05/2023
Riya Gandhi, MA
New research reveals a web of associated conditions and financial and access burdens, paving the way for a more comprehensive approach to patient care.
New research reveals a web of associated conditions and financial and access burdens, paving the way for a more comprehensive approach to patient care.
New research reveals a web of...
12/05/2023
The Dermatologist
NEA Approved Features
Safety of Topical Medications in Pediatric Atopic Dermatitis
09/11/2023
Jessica Garlewicz
Dr Peter Lio provides a brief on the current topicals used to treat atopic dermatitis in children.
Dr Peter Lio provides a brief on the current topicals used to treat atopic dermatitis in children.
Dr Peter Lio provides a brief on...
09/11/2023
The Dermatologist

News

News
Dental Personnel Are At Risk of Developing Occupational Contact Dermatitis
01/31/2022
Jessica Garlewicz
Researchers aimed to determine the prevalence of occupational contact dermatitis in dental personnel referred for patch testing and characterize relevant allergens.
Researchers aimed to determine the prevalence of occupational contact dermatitis in dental personnel referred for patch testing and characterize relevant allergens.
Researchers aimed to determine...
01/31/2022
The Dermatologist
News
Atopic Dermatitis Poses Significant Financial Burden on Patients
11/03/2021
Lauren Mateja
Researchers found that atopic dermatitis poses a significant burden on direct and indirect health care costs for adults with the disease.
Researchers found that atopic dermatitis poses a significant burden on direct and indirect health care costs for adults with the disease.
Researchers found that atopic...
11/03/2021
The Dermatologist
News
Study Results Hint at Relationship Between Addiction and Atopic Dermatitis
11/03/2021
Lauren Mateja
There may be elevated positive screening rates for addictive behaviors in people with atopic dermatitis (AD) vs the general population.
There may be elevated positive screening rates for addictive behaviors in people with atopic dermatitis (AD) vs the general population.
There may be elevated positive...
11/03/2021
The Dermatologist
News
Atopic Dermatitis Associated with Cardiovascular Disease
09/24/2021
Lisa Kuhns, PhD, MD
Patients with atopic dermatitis (AD) and metabolic disorders are at risk for developing cardiovascular disease (CVD) and major cardiovascular events (MACE), according to a study published in Dermatology and Therapy. Researchers aimed to...
Patients with atopic dermatitis (AD) and metabolic disorders are at risk for developing cardiovascular disease (CVD) and major cardiovascular events (MACE), according to a study published in Dermatology and Therapy. Researchers aimed to...
Patients with atopic dermatitis...
09/24/2021
The Dermatologist
News
World Eczema Day: Patient-Led Initiative to Improve Eczema Care
09/14/2021
The Global Patient Initiative to Improve Eczema Care seeks to establish a standardized patient-perspective assessment of atopic dermatitis care.
The Global Patient Initiative to Improve Eczema Care seeks to establish a standardized patient-perspective assessment of atopic dermatitis care.
The Global Patient Initiative to...
09/14/2021
The Dermatologist
News
Upadacitinib Safe, Effective Therapy for Patients With AD in Comparator Trial
08/25/2021
Lisa Kuhns, PhD, MD
Upadacitinib demonstrated better efficacy in patients with moderate to severe atopic dermatitis and is a safe treatment option.
Upadacitinib demonstrated better efficacy in patients with moderate to severe atopic dermatitis and is a safe treatment option.
Upadacitinib demonstrated better...
08/25/2021
The Dermatologist
News
NEA Amplifies Patient Voice During the Institute for Clinical and Economic Review Meeting
08/25/2021
Lisa Kuhns, PhD, MD
The National Eczema Association amplified the patient voice in the evaluation of new treatments in a public meeting held by the Institute for Clinical and Economic Review.
The National Eczema Association amplified the patient voice in the evaluation of new treatments in a public meeting held by the Institute for Clinical and Economic Review.
The National Eczema Association...
08/25/2021
The Dermatologist
News
Efficacy, Mode of Administration, and Side Effects are Important in AD Treatment Preferences
08/10/2021
Lisa Kuhns, PhD, MD
AD treatment attributes that are the most important for patients and caregivers are efficacy, mode of administration, and side effects.
AD treatment attributes that are the most important for patients and caregivers are efficacy, mode of administration, and side effects.
AD treatment attributes that are...
08/10/2021
The Dermatologist
News
Capillaroscopic Examination Should Be Performed in Children With Atopic Dermatitis
06/24/2021
Lisa Kuhns, PhD, MD
Nail changes can be detected in children with atopic dermatitis, according to a recent study published in Clinical and Experimental Dermatology.
Nail changes can be detected in children with atopic dermatitis, according to a recent study published in Clinical and Experimental Dermatology.
Nail changes can be detected in...
06/24/2021
The Dermatologist
News
Threshold of Clinically Meaningful Within-Patient Changes in POEM and CDLQI in Children 6 to 11 Years of Age With Severe Atopic Dermatitis Defined
06/24/2021
Lisa Kuhns, PhD, MD
A recent study defined clinically meaningful within-patient changes in Patient-Oriented Eczema Measure and Children’s Dermatology Life Quality Index in children with severe atopic dermatitis.
A recent study defined clinically meaningful within-patient changes in Patient-Oriented Eczema Measure and Children’s Dermatology Life Quality Index in children with severe atopic dermatitis.
A recent study defined...
06/24/2021
The Dermatologist
psoriasis0
News
Altered Lysine Crotonylation Identified in Psoriatic Skin
03/19/2026
Jessica Garlewicz
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a...
03/19/2026
The Dermatologist
atopic dermatitis
News
Mixed Associations Between Socioeconomic Status and Pediatric Atopic Dermatitis Highlight Research Gaps
03/11/2026
Jessica Garlewicz
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to...
03/11/2026
The Dermatologist
psoriasis
News
Biologic Therapy Improves Psychological Well-Being and Quality of Life in Psoriasis
03/03/2026
Jessica Garlewicz
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for...
03/03/2026
The Dermatologist
psoriasis
News
Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis
02/03/2026
Jessica Garlewicz
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms...
02/03/2026
The Dermatologist
psoriasis
News
Mathematical Modeling Study Highlights Cytokine Balance and Stem Cell Feedback in Psoriasis Control
01/22/2026
Jessica Garlewicz
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study...
01/22/2026
The Dermatologist
Cutaneous Squamous Cell Carcinoma
News
Managing Cutaneous Squamous Cell Carcinoma
01/06/2026
Jessica Garlewicz
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review...
01/06/2026
The Dermatologist
psoriatic arthritis
News
Rare Case Highlights Diagnostic and Treatment Challenges in PsA–Myopathy Overlap
09/02/2025
Jessica Garlewicz
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a...
09/02/2025
The Dermatologist
psoriatic arthritis
News
Real-World Data Support ITABIO Guidelines for Second-Line Biologic Use in Inflammatory Arthritis
09/02/2025
Jessica Garlewicz
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment...
09/02/2025
The Dermatologist
psoriasis
News
Study Links Hypothyroidism to Psoriasis, Independent of Disease Severity
09/02/2025
Jessica Garlewicz
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that...
09/02/2025
The Dermatologist
psoriasis
News
Beta-Blockers Not Linked to Increased Psoriasis Risk, Study Finds
09/02/2025
Jessica Garlewicz
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis...
09/02/2025
The Dermatologist
April/May 2026 cover

Current Issue

April 2026
Volume 34
Issue 3
Current Issue
Issue Archive
The Dermatologist Newsletter

More Atopic Dermatitis Content

NEA Approved Features
Supporting the Transition to Self-Managed Care in Adolescents and Young Adults With Atopic Dermatitis
03/09/2026
Allison Loiselle, PhD; Jessica Garlewicz
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association...
03/09/2026
The Dermatologist
Dr Guttman
Conference Coverage
Atopic Dermatitis: OX40, IL-31, Treg Therapy, and the JAK Head-to-Head Era
02/21/2026
Riya Gandhi, MA
A dermatology update on atopic dermatitis therapeutics, highlighting dupilumab, lebrikizumab, nemolizumab, rocatinlimab (OX40), amlitelimab (OX40L), rezpegaldesleukin, and oral JAK inhibitors (upadacitinib, abrocitinib).
A dermatology update on atopic dermatitis therapeutics, highlighting dupilumab, lebrikizumab, nemolizumab, rocatinlimab (OX40), amlitelimab (OX40L), rezpegaldesleukin, and oral JAK inhibitors (upadacitinib, abrocitinib).
A dermatology update on atopic...
02/21/2026
The Dermatologist
Dr Guttman
Conference Coverage
Chronic Hand Eczema: From Pathogenic Subtypes to Targeted JAK and IL-4/13 Therapy
02/20/2026
Riya Gandhi, MA
A clinical update on chronic hand eczema, highlighting delgocitinib cream, ruxolitinib, gusacitinib, dupilumab, tralokinumab, and biomarker-driven Th1/Th2/Th17 endotypes.
A clinical update on chronic hand eczema, highlighting delgocitinib cream, ruxolitinib, gusacitinib, dupilumab, tralokinumab, and biomarker-driven Th1/Th2/Th17 endotypes.
A clinical update on chronic...
02/20/2026
The Dermatologist
NEA Approved Features
Patient Self-Monitoring and Shared Decision-Making in Atopic Dermatitis
12/09/2025
Jessica Garlewicz
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to...
12/09/2025
The Dermatologist
atopic dermatitis
Conference Coverage
Clarifying the Role of IL-13 Inhibitors in Atopic Dermatitis: Clinical Profiles, Comparisons, and Real-World Application
11/26/2025
Jessica Garlewicz
The session emphasized mechanism-driven selection, real-world application, and a comparison of pivotal efficacy data for the 3 IL-13–related biologics currently available: dupilumab, lebrikizumab, and tralokinumab.
The session emphasized mechanism-driven selection, real-world application, and a comparison of pivotal efficacy data for the 3 IL-13–related biologics currently available: dupilumab, lebrikizumab, and tralokinumab.
The session emphasized...
11/26/2025
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use